Error: Could not add to watchlist. X
+ Watchlist

RXi Pharmaceuticals Corp

RXII:US
NASDAQ CM
2.491
USD
0.091
3.80%
As of 10:18 AM EDT 7/27/2016
Open
2.440
Day Range
2.440 - 2.640
Volume
48,679
Previous Close
2.400
52Wk Range
1.260 - 6.494
1 Yr Return
-47.27%
Open
2.440
Day Range
2.440 - 2.640
Volume
48,679
Previous Close
2.400
52Wk Range
1.260 - 6.494
1 Yr Return
-47.27%
YTD Return
-34.79%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.700
Market Cap (m USD)
15.684
Shares Outstanding (m)
6.535
Price/Sales (TTM)
161.97
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercialization therapies addressing major unmet medical needs using RNAI-targeted technologies. The Company's proprietary RNA interference is a naturally occurring cellular mechanism that interferes with and silences expression of targeted disease-associated genes.
Address
60 Prescott Street
Worcester, MA 01605
United States
Phone
1-508-767-3861
Show More